PODD News & Events

Insulet Corporation announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System and its proprietary data management system Omnipod Discover in Spain, the Company's newest European market. Spain is the 26th country where Insulet sells Omnipod, and the 20th country where Omnipod 5 is available, further accelerating Insulet's mission to transform the lives of people with diabetes around the world.

The FDA said it is aware that Insulet issued a letter to affected customers recommending certain Omnipod Pods be removed from where they are used or sold. The affected devices are Omnipod 5 Automated Insulin Delivery System, Omnipod DASH Insulin Management System, and Omnipod Insulin Management System. Insulet identified that some Pods from specific lots may have a small tear in the tubing just above the skin, between the Pod and the point where the cannula enters the body. As of May 20, Insulet reported 24 serious injuries and no deaths associated with this issue.

Insulet Corporation announced the appointment of Jonathan Mazelsky to the Company's Board of Directors, effective July 1, 2026. Mazelsky joins the Board as an independent director.